Chromatic CRE contains a mixture of carbapenems for screening a wide variety of carbapenem-resistance mechanisms and provides presumptive identification of E. coli and the Klebsiella, Enterobacter, Serratia and Citrobacter (KESC) group directly from clinical specimens.
Carbapenems, successfully used to treat multi-resistant Gram-negative bacterial infections, including ESBL positive strains, are not efficacious against the Enterobacteriaceae resistant to carbapenems, thus generating a significant risk of hospital-acquired infections.
Microrganism
Carbapenem-resistant Klebsiella pneumoniae
Carbapenem-resistant Escherichia coli
Carbapenem-resistant Enterobacter spp.
Carbapenem-resistant Citrobacter spp.
Carbapenem-resistant Non Enterobacteriaceae
Other microorganisms
Typical appearance of the colonies
Blue-violet
Red Blue-green
Blue with red halo
White to natural pigmented
Inhibited
Chromatic CRE è disponibile in confezioni da 20 piastre pronte all'uso, Liofilchem cod. 11619.